Partnership

Homepage - Torlak Institute

Messenger Biopharma has established a partnership with the Torlak Institute for the development of an mRNA vaccine against the West Nile Virus.

Last news

photo labo 2

Messenger Biopharma licenses its Nuntius biotechnology to mRNA players

posted October 28, 2024

Read More

Recent Search Keywords